|
|
|
Volumn 31, Issue 6, 2004, Pages 959-961
|
|
A case of advanced pancreatic cancer with remarkable response to thalidomide, celecoxib and gemcitabine
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
CELECOXIB;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
ISOENZYME;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PTGS2 PROTEIN, HUMAN;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
THALIDOMIDE;
AGED;
ARTICLE;
CASE REPORT;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
ORAL DRUG ADMINISTRATION;
PANCREAS TUMOR;
PATHOLOGY;
ADMINISTRATION, ORAL;
AGED;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
INFUSIONS, INTRAVENOUS;
ISOENZYMES;
MALE;
MEMBRANE PROTEINS;
PANCREATIC NEOPLASMS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PYRAZOLES;
SULFONAMIDES;
THALIDOMIDE;
|
|
EID: 3042535469
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
